Ads
related to: medicine, pharmaceuticals
Search results
Cycle Pharmaceuticals offers to acquire Vanda Pharma for $466m
Pharmaceutical Technology via Yahoo Finance· 13 hours agoThe company also reported net sales of $109m and an operating profit of $40m in 2023. Cycle ...
Acid for the ear
Politico· 5 hours agoThe Pentagon is investigating how psychedelic medicine can help servicemembers — beyond mental health issues. The agency has awarded $825,000 to...
Job fair for university graduates held in Yunnan
China Daily· 8 minutes agoA job fair for university graduates was held at Yunnan Minzu University, in Southwest China's Yunnan province on Wednesday, according to news portal ynet.com.
Teva Pharmaceutical Industries (NYSE:TEVA) Price Target Raised to $21.00 at Barclays
ETF DAILY NEWS· 20 hours agoTeva Pharmaceutical Industries (NYSE:TEVA – Get Free Report) had its price target upped by Barclays from $20.00 to $21.00 in a research note issued to investors on Wednesday ...
Pharma Stock Roundup: LLY's CFO Departs, ABBV, AZN Drugs Get CHMP Approval
Zacks via Yahoo Finance· 9 hours agoThe application was based on data from the FLAURA2 phase III study. Tagrisso was approved for...
Changing Your Diet and Lifestyle May Slow Down Alzheimer's
Time via AOL· 21 hours agoAdministration is expected to make a decision about another such promising therapy. But in addition...
Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Receives $20.25 Consensus Target Price from Brokerages
ETF DAILY NEWS· 21 hours agoFusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Free Report) has been assigned a consensus rating of...
Bayer and PAPACKS to redefine consumer health packaging
Packaging Gateway via Yahoo Finance· 13 hours agoPharmaceutical and biotechnology company Bayer has collaborated with packaging provider PAPACKS on...
Collegium Pharmaceutical (NASDAQ:COLL) Upgraded to Buy by Jefferies Financial Group
ETF DAILY NEWS· 16 hours agoCollegium Pharmaceutical (NASDAQ:COLL – Get Free Report) was upgraded by stock analysts at Jefferies Financial Group from a “hold” rating to a “buy” rating in a report released ...
Why Is Apellis Pharmaceuticals (APLS) Down 1.9% Since Last Earnings Report?
Zacks via Yahoo Finance· 1 day agoIt turns out, estimates review have trended upward during the past month. The consensus estimate has...